TY - JOUR
T1 - Working with companies that manufacture breastmilk substitutes
T2 - An EAACI position paper
AU - Arasi, Stefania
AU - Caubet, Jean Christoph
AU - Ceylan, Ozlem
AU - Eguíluz-Gracia, Ibon
AU - Del Giacco, Stefano
AU - Gelincik, Aslı
AU - Jutel, Marek
AU - Meyer, Rosan
AU - Ollert, Markus
AU - Torres, Maria J.
N1 - Publisher Copyright:
© 2024 The Authors. Pediatric Allergy and Immunology published by European Academy of Allergy and Clinical Immunology and John Wiley & Sons Ltd.
PY - 2024/5
Y1 - 2024/5
N2 - Breastmilk is the optimal source of nutrition for infants and should ideally be provided exclusively for the first 6 months of life, and alongside complementary food until 2 years of life. However, there are circumstances where a breastmilk substitute (BMS) may be required. This includes maternal and/or child conditions or personal preference. Whilst these circumstances should never be used as an opportunity to promote BMS, healthcare professionals (HCPs) need to have the knowledge of suitable alternatives and should always be guided by scientific and health motives when recommending a BMS. The Task Force ‘Milk Formula Industry Sponsorship’ from the European Academy of Allergy and Clinical Immunology (EAACI), provides with this publication recommendations for EAACI interactions with the BMS manufacturers and how this will be supervised.
AB - Breastmilk is the optimal source of nutrition for infants and should ideally be provided exclusively for the first 6 months of life, and alongside complementary food until 2 years of life. However, there are circumstances where a breastmilk substitute (BMS) may be required. This includes maternal and/or child conditions or personal preference. Whilst these circumstances should never be used as an opportunity to promote BMS, healthcare professionals (HCPs) need to have the knowledge of suitable alternatives and should always be guided by scientific and health motives when recommending a BMS. The Task Force ‘Milk Formula Industry Sponsorship’ from the European Academy of Allergy and Clinical Immunology (EAACI), provides with this publication recommendations for EAACI interactions with the BMS manufacturers and how this will be supervised.
KW - breastmilk
KW - breastmilk substitutes
KW - feed for special medical purpose
KW - food allergy
KW - industry
UR - http://www.scopus.com/inward/record.url?scp=85193313659&partnerID=8YFLogxK
UR - https://pubmed.ncbi.nlm.nih.gov/38753422
U2 - 10.1111/pai.14142
DO - 10.1111/pai.14142
M3 - Article
C2 - 38753422
AN - SCOPUS:85193313659
SN - 0905-6157
VL - 35
JO - Pediatric Allergy and Immunology
JF - Pediatric Allergy and Immunology
IS - 5
M1 - e14142
ER -